<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063861/" ref="ordinalpos=125&amp;ncbi_uid=3656584&amp;link_uid=PMC3063861" image-link="/pmc/articles/PMC3063861/figure/F1/" class="imagepopup">Figure 1. GPCR <span class="highlight" style="background-color:">signaling</span>.  From: ?-arrestin: a <span class="highlight" style="background-color:">signaling</span> molecule and potential therapeutic target for heart failure. </a></div><br /><div class="p4l_captionBody">In response to ligand stimulation, GPCR signaling can occur via both G-protein mediated pathway (which leads to activation of second messengers) or via Î²-arrestin mediated pathway which further stimulate a plethora of downstream signaling pathways (MAPK, PI3K, AKT, EGFR etc.) (Reproduced with permission from Ref [31]).</div></div>